Antibody/Targeted-Drug Conjugates 2017

22-24 March 2017, Leiden University Medical Centre, Leiden, The Netherlands

  • Increase font size
  • Default font size
  • Decrease font size

Participation

Abstract Submissions

The ATDC 2017 Scientific Advisory Panel require authors to submit a one page abstract for each paper they wish to be considered for inclusion in the oral and/or poster programs during ATDC 2017. The one page abstract should contain sufficient information for the Scientific Advisory Panel to be able to make a valid decision as to the intrinsic merit of the paper and its relevance to the aims of the conference. Authors should indicate on the reply form whether they prefer oral or poster presentation. Proposals are also invited for panel discussions and special workshops – these special sessions may be scheduled during the daytime conference timetable or alternatively can be allocated as either breakfast or evening sessions.

Abstract proposals should be sent for the attention of John Herriot at Meetings Management (ATDC 2017 Conference Organisers). Authors should send their abstract(s) using the Call for Participation Reply Form or by e-mail to John Herriot (please attach abstracts as Word documents).

Closing date for submissions intended for oral presentation: Wednesday 16th November 2016. Authors will be informed of the status of their contribution(s) in December 2016. Closing date for submissions intended for poster presentation: Friday 3rd March 2017.

Publication

Abstracts of all papers to be presented (oral and poster) will be included on a USB device which will be distributed to delegates on registration. All submissions will be refereed in the normal fashion and will be published subsequent to the conference.

Participation

All non-invited speakers will be expected to register as delegates to ATDC 2017. Registration will require speakers to pay a registration fee to attend the conference. Travel and accommodation expenses are the responsibility of each non-invited speaker and no direct compensation is awarded for speakers at ATDC 2017. Your submission of an abstract testifies to the fact that you will accept these financial conditions.

 

ATDC 2017 Delegates

Login details will be supplied after you have registered for the event.


ATDC 2017 Sponsors

  • ImmunoGen
  • Genentech
  • LinXis
  • ONdrugDelivery
  • Pfizer Oncology
  • Genovis
  • NBE Therapeutics
  • Sutro BioPharma
  • Lonza
  • Oncozine
  • Cancer Targeting Solutions Consultancy
  • Catalent
  • NatureGeneTherapy.com
  • Aldevron
  • ADC Review

ATDC 2017 Downloads

ATDC 2017 Leaflet

ATDC 2017 Mailing List

Name
E-mail Address
What is 3+2-1?